Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

Little is known about the impact of multiple myeloma (MM) treatment on uninvolved immunoglobulins (Ig). We identified 448 patients who received high-dose dexamethasone (HD-DEX), lenalidomide and dexamethasone (RD), bortezomib and dexamethasone (VD), bortezomib, cyclophosphamide and dexamethasone (VC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravi, P, Kumar, S, Gonsalves, W, Buadi, F, Lacy, M Q, Go, R S, Dispenzieri, A, Kapoor, P, Lust, J A, Dingli, D, Lin, Y, Russell, S J, Leung, N, Gertz, M A, Kyle, R A, Bergsagel, P L, Rajkumar, S V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584483/
https://www.ncbi.nlm.nih.gov/pubmed/28622306
http://dx.doi.org/10.1038/bcj.2017.46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584483/
https://www.ncbi.nlm.nih.gov/pubmed/28622306
http://dx.doi.org/10.1038/bcj.2017.46

Ejemplares similares